Prevalence of clinical and neuroimaging markers in cerebral amyloid angiopathy: a systematic review and meta-analysis
K Malhotra, A Theodorou, AH Katsanos, C Zompola… - Stroke, 2022 - Am Heart Assoc
Background: Limited data exist regarding the prevalence of clinical and neuroimaging
manifestations among patients diagnosed with cerebral amyloid angiopathy (CAA). We …
manifestations among patients diagnosed with cerebral amyloid angiopathy (CAA). We …
Prevalence of Clinical and Neuroimaging Markers in Cerebral Amyloid Angiopathy: A Systematic Review and Meta-Analysis.
K Malhotra, A Theodorou, AH Katsanos, C Zompola… - Stroke, 2022 - europepmc.org
Background Limited data exist regarding the prevalence of clinical and neuroimaging
manifestations among patients diagnosed with cerebral amyloid angiopathy (CAA). We …
manifestations among patients diagnosed with cerebral amyloid angiopathy (CAA). We …
Prevalence of Clinical and Neuroimaging Markers in Cerebral Amyloid Angiopathy: A Systematic Review and Meta-Analysis
K Malhotra, A Theodorou, AH Katsanos… - Stroke, 2022 - pubmed.ncbi.nlm.nih.gov
Background Limited data exist regarding the prevalence of clinical and neuroimaging
manifestations among patients diagnosed with cerebral amyloid angiopathy (CAA). We …
manifestations among patients diagnosed with cerebral amyloid angiopathy (CAA). We …
Prevalence of Clinical and Neuroimaging Markers in Cerebral Amyloid Angiopathy: A Systematic Review and Meta-Analysis
K Malhotra, A Theodorou, AH Katsanos, C Zompola… - Stroke, 2022 - discovery.ucl.ac.uk
BACKGROUND: Limited data exist regarding the prevalence of clinical and neuroimaging
manifestations among patients diagnosed with cerebral amyloid angiopathy (CAA). We …
manifestations among patients diagnosed with cerebral amyloid angiopathy (CAA). We …
Prevalence of Clinical and Neuroimaging Markers in Cerebral Amyloid Angiopathy: A Systematic Review and Meta-Analysis
K Malhotra, C Zompola, AH Katsanos, A Shoamanesh… - Stroke, 2022 - ikee.lib.auth.gr
Background Limited data exist regarding the prevalence of clinical and neuroimaging
manifestations among patients diagnosed with cerebral amyloid angiopathy (CAA). We …
manifestations among patients diagnosed with cerebral amyloid angiopathy (CAA). We …
Prevalence of Clinical and Neuroimaging Markers in Cerebral Amyloid Angiopathy: A Systematic Review and Meta-Analysis
K Malhotra, A Theodorou, AH Katsanos, C Zompola… - Stroke, 2022 - Am Heart Assoc
BACKGROUND: Limited data exist regarding the prevalence of clinical and neuroimaging
manifestations among patients diagnosed with cerebral amyloid angiopathy (CAA). We …
manifestations among patients diagnosed with cerebral amyloid angiopathy (CAA). We …
Prevalence of Clinical and Neuroimaging Markers in Cerebral Amyloid Angiopathy: A Systematic Review and Meta-Analysis
K Malhotra, A Theodorou, AH Katsanos, C Zompola… - Stroke, 2022 - ingentaconnect.com
Background: Limited data exist regarding the prevalence of clinical and neuroimaging
manifestations among patients diagnosed with cerebral amyloid angiopathy (CAA). We …
manifestations among patients diagnosed with cerebral amyloid angiopathy (CAA). We …
[引用][C] Prevalence of Clinical and Neuroimaging Markers in Cerebral Amyloid Angiopathy: A Systematic Review and Meta-Analysis.
K Malhotra, A Theodorou, AH Katsanos, C Zompola… - 2022 - lilloa.univ-lille.fr
Prevalence of Clinical and Neuroimaging Markers in Cerebral Amyloid Angiopathy: A
Systematic Review and Meta-Analysis. Toggle navigation English français Aide | Contact | À …
Systematic Review and Meta-Analysis. Toggle navigation English français Aide | Contact | À …